Clinical Trials Logo

Thyroid Diseases clinical trials

View clinical trials related to Thyroid Diseases.

Filter by:

NCT ID: NCT04076514 Recruiting - Clinical trials for Papillary Thyroid Cancer

The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma

pCND
Start date: September 1, 2020
Phase:
Study type: Observational

The benefits of prophylactic central neck dissection (pCND) remain controversial in clinically node-negative (cN0) papillary thyroid carcinoma (PTC). This study main goal is to investigate benefits of prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma.

NCT ID: NCT04075851 Recruiting - Clinical trials for Autoimmune Thyroid Disease

The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases

Start date: August 1, 2019
Phase:
Study type: Observational

Thyroid hormone autoantibodies(THAA) in serum can Interfere radioimmunoassay for the determination of free thyroid hormones. Thyroid function test plays a key role in the diagnosis and treatment of autoimmune thyroid disease (AITD), and abnormal examination results in misdiagnosis and mistreatment. At present, the epidemiological results of THAA in AITD are inconsistent, and the pathogenesis has not been clarified. However, there is no relevant research on THAA in China. This project intends to collect AITD patients and healthy people, detecting THAA, at the same time testing thyroid function and thyroid autoantibodies, definiting positive rate of THAA in AITD patients, observing the effect of common therapeutic drugs for AITD on THAA, investigating the rule of THAA influencing thyroid function test results .This project will provide the basis and method for how to effectively avoid THAA interfering with thyroid function test.

NCT ID: NCT04072731 Completed - Thyroid Cancer Clinical Trials

SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer

Start date: January 16, 2016
Phase:
Study type: Observational

In this study, the investigators detected the expression of SREBP1 in thyroid cancer tissues, explored the biological functions of SREBP1 in thyroid cancer cells.

NCT ID: NCT04061980 Recruiting - Clinical trials for Metastatic Thyroid Gland Carcinoma

Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer

Start date: October 30, 2020
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well encorafenib and binimetinib given with or without nivolumab works in treating patients with BRAF V600 mutation positive thyroid cancer that has spread to other places in the body (metastatic) and does not respond to radioiodine treatment (refractory). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body?s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The trial aims to find out if the combination of encorafenib and binimetinib, with and without study nivolumab, is a safe and effective way to treat metastatic radioiodine refractory thyroid cancer.

NCT ID: NCT04051099 Recruiting - Hyperparathyroidism Clinical Trials

Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

To compare efficacy and safety between bilateral superficial cervical plexus block combined with intravenous sedation (RA group) and general anesthesia (GA group) for thyroid and parathyroid operations. This study evaluates postoperative numerical pain score and systemic opioid requirement within 24 hours.

NCT ID: NCT04046354 Active, not recruiting - Ablation Clinical Trials

Microwave vs. Radiofrequency Ablation for Benign Thyroid Nodules: A Multicenter Randomized Controlled Trial Study

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Compared with traditional treatment methods, ultrasound-guided thermal ablation is more targeted, less invasive and more reliable. The study compared microwave ablation and radiofrequency ablation to evaluate the efficacy and safety in the treatment of benign thyroid nodules with a multicenter data, which will provide a basis for clinical treatment.

NCT ID: NCT04040894 Approved for marketing - Thyroid Eye Disease Clinical Trials

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

EAP
Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access protocol intended to provide access to teprotumumab for the treatment of up to 60 patients in the United States with active moderate to severe thyroid eye disease where there is no comparable or satisfactory alternative therapy for treatment.

NCT ID: NCT04040673 Not yet recruiting - Thyroid Cancer Clinical Trials

RAman For Thyroid cancER

RAFTER
Start date: June 1, 2024
Phase:
Study type: Observational

Ex vivo vibrational spectroscopy (VS), including Raman spectroscopy (RS) of thyroid tissue samples, collected from patients undergoing routine diagnostic thyroid biopsies for diagnosis of potential thyroid cancer. Raman spectra are to be correlated with consensus histopathology and clinical outcomes. Multivariate analysis to be used to evaluate the classification accuracy of VS ex vivo.

NCT ID: NCT04031638 Recruiting - Clinical trials for Patients With a Thyroid Tumor Who Received Radioactive Iodine Treatment

Thyroid Cancer Database

Start date: January 1, 2000
Phase:
Study type: Observational

Thyroid cancer database collects clinical and laboratory data from patients with a thyroid tumor who received radioactive Iodine treatment. This database only records information based on patients' medical files in a structured manner. Thyroid database is used for retrospective non-interventional research projects.

NCT ID: NCT04031339 Recruiting - Thyroid Neoplasms Clinical Trials

Study of Clinical Outcomes of Thyroid Cancer

ITCO
Start date: January 1, 2013
Phase:
Study type: Observational

The Italian Thyroid Cancer Observatory (ITCO) repository was established to collect data on thyroid cancer management in a prospective and consecutive series of newly-diagnosed patients, enrolled in centers uniformly distributed across the nation.